Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the full record of transactions filed by SIDRANSKY DAVID, Director. Director active across 3 companies, notably Champions Oncology, INC.. In total, 4 reports have been published. Activity tracked since 15 October 2021. The latest transaction was disclosed on 12 October 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
4 of 4 declarations
David Sidransky is a Board Member of CHAMPIONS ONCOLOGY, INC. In this role, he participates in strategic decisions and governance of the company. Sidransky brings his expertise in oncology and business, helping to guide the company's direction. His experience is valuable for the board and for the development of the company's initiatives.